Royal Bank of Canada’s CalciMedica CALC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-250
Closed -$1K 6910
2024
Q3
$1K Buy
+250
New +$1.1K ﹤0.01% 6689
2022
Q2
Sell
-71
Closed -$1K 7388
2022
Q1
$1K Hold
71
﹤0.01% 7576
2021
Q4
$2K Hold
71
﹤0.01% 7390
2021
Q3
$3K Sell
71
-34
-32% -$1.91K ﹤0.01% 7255
2021
Q2
$8K Buy
105
+64
+156% +$4.2K ﹤0.01% 6940
2021
Q1
$3K Buy
41
+19
+86% +$5.69K ﹤0.01% 7146
2020
Q4
$9K Buy
+22
New +$6.49K ﹤0.01% 6412

Other funds holding CALC

Royal Bank of Canada's CALC Position: Q4 2024 in Review

Royal Bank of Canada sold out of CalciMedica (CALC) in Q4 2024, closing a stake of 250 shares — an estimated $1K sold.

Royal Bank of Canada first reported a position in CALC in Q4 2020 and held it in 7 quarters. The position peaked at $9K in Q4 2020. 29 funds tracked by Wall St. Rank hold CALC as of Q4 2024.

  • Royal Bank of Canada reported no remaining CalciMedica position as of Q4 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 250 CalciMedica shares in Q4 2024, an estimated $1K.
  • Royal Bank of Canada first reported a position in CalciMedica in Q4 2020 and held it in 7 quarters.
  • Royal Bank of Canada's CalciMedica position peaked at $9K in Q4 2020.
  • 29 funds tracked by Wall St. Rank held CalciMedica as of Q4 2024.

Based on Royal Bank of Canada's 13F filing for Q4 2024, filed 14 Feb 2025.